Allogene Therapeutics
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic ...load more
Allogene Therapeutics's Basic Information
Industry
Headquarters
South San Francisco, California, United States
Website
Founded Year
2018
Headcount
201 - 500 ( View All )
Specialties
biotechnologyimmunotherapyCAR Toncologycancer
Allogene Therapeutics's Competitors
Employee Insights
Allogene Therapeutics's Top Employees
Frequently Asked Questions Regarding Allogene Therapeutics
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts